CATALOGO DEI PRODOTTI DELLA RICERCA

COLOMBATTI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.944
EU - Europa 4.877
AS - Asia 3.417
SA - Sud America 521
AF - Africa 41
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.815
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.843
GB - Regno Unito 2.146
SG - Singapore 1.381
CN - Cina 1.231
BR - Brasile 475
SE - Svezia 461
HK - Hong Kong 393
FI - Finlandia 362
DE - Germania 353
IE - Irlanda 343
FR - Francia 336
RU - Federazione Russa 328
IT - Italia 238
UA - Ucraina 119
KR - Corea 86
VN - Vietnam 64
CA - Canada 57
TR - Turchia 53
BE - Belgio 45
IN - India 38
NL - Olanda 38
JP - Giappone 30
MX - Messico 29
IR - Iran 28
ES - Italia 21
BD - Bangladesh 20
AT - Austria 18
IQ - Iraq 15
AR - Argentina 14
ZA - Sudafrica 13
PL - Polonia 12
ID - Indonesia 11
AU - Australia 8
CH - Svizzera 8
CO - Colombia 8
MA - Marocco 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
EC - Ecuador 6
LT - Lituania 6
PA - Panama 6
PT - Portogallo 6
UZ - Uzbekistan 6
UY - Uruguay 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
EG - Egitto 4
EU - Europa 4
LV - Lettonia 4
PK - Pakistan 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
VE - Venezuela 4
CL - Cile 3
HR - Croazia 3
IL - Israele 3
JM - Giamaica 3
JO - Giordania 3
NP - Nepal 3
PE - Perù 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CM - Camerun 2
CY - Cipro 2
ET - Etiopia 2
GR - Grecia 2
GY - Guiana 2
HU - Ungheria 2
IS - Islanda 2
KE - Kenya 2
KH - Cambogia 2
KW - Kuwait 2
KZ - Kazakistan 2
LU - Lussemburgo 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BT - Bhutan 1
CG - Congo 1
DK - Danimarca 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
ME - Montenegro 1
MN - Mongolia 1
Totale 15.807
Salva come PNG Salva come JPEG
Città #
Southend 1.866
Jacksonville 1.013
Chandler 875
Woodbridge 723
Dallas 674
Singapore 643
Ann Arbor 489
Ashburn 402
Hong Kong 384
Dublin 343
Houston 261
Beijing 202
Buffalo 165
Los Angeles 158
Wilmington 150
Lawrence 132
Princeton 132
Jinan 122
Nanjing 112
New York 99
Shenyang 99
Helsinki 88
Verona 83
The Dalles 78
Munich 67
Boardman 65
Hebei 64
Columbus 57
Tianjin 56
Seattle 52
Brussels 45
Changsha 44
Sindelfingen 42
Zhengzhou 41
Taizhou 37
Ningbo 34
Cambridge 33
Milan 33
Nanchang 32
São Paulo 32
Fairfield 31
Haikou 30
Hangzhou 30
Jiaxing 30
Philadelphia 29
San Francisco 29
Santa Clara 29
Turku 29
Falls Church 27
Guangzhou 27
Seoul 27
Norwalk 25
Taiyuan 24
Tokyo 23
Fuzhou 22
Auburn Hills 18
Council Bluffs 18
Lancaster 18
London 18
Amsterdam 16
Lanzhou 15
Brooklyn 14
Frankfurt am Main 14
Hanoi 13
Ho Chi Minh City 13
Montreal 13
Belo Horizonte 12
Bologna 12
Montréal 12
Nuremberg 12
Redwood City 12
Stockholm 12
Chicago 11
Detroit 11
Redondo Beach 11
Rio de Janeiro 11
Brasília 10
Chennai 10
Phoenix 10
Atlanta 9
Edinburgh 9
Falkenstein 9
Kent 9
Warsaw 9
Boston 8
Dong Ket 8
Jakarta 8
San Mateo 8
Tehran 8
Vienna 8
Augusta 7
Dearborn 7
Denver 7
Elora 7
Johannesburg 7
Mexico City 7
Moscow 7
Padova 7
Porto Alegre 7
Rome 7
Totale 10.918
Salva come PNG Salva come JPEG
Nome #
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 220
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 203
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 201
Anti PSMA immunotoxins activity against prostate cancer cell lines. 195
Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity 187
Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates 183
Carrier protein-monensin conjugates: enhancement of immunotoxin cytotoxicity and potential in tumor treatment 183
Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction 177
Immunotoxins and other conjugates: preparation and general characteristics. 174
Anti-tumor effects of toxins targeted to the prostate specific membrane antigen. 167
Anti-PSMA-Immunotoxins: a new therapeutical strategy for selective targeting of toxins to prostate cancer cells. 161
Adhesion of immature and mature T cells induces in human thymic epithelial cells (TEC) activation of IL-6 gene trascription factors (NF-kappaB and NF-IL6) and IL-6 gene expression: role of alpha3beta1 and alpha6beta4 integrins. 160
Escape mechanisms of human leukemic cells to long-term immunotoxin treatment in an in vitro experimental model 155
Distribution of endocytosed molecules to intracellular acidic environments correlates with immunotoxin activity 154
Reductive activation of ricin and ricin-A chain immunotoxins by Protein Disulfide Isomerase and Thioredoxin Reductase system. 154
Cytoreductive effects of anti-transferrin receptor immunotoxin in a multicellular tumor spheroid model 153
Monoclonal antibodies against ricin: effects on toxin function 153
Apical transport and folding of prostate-specific membrane antigen occurs independent of glycan processing. 152
Anti PSCA Monoclonal Antibody and scFv-Fragment for Immunotherapy of Prostate, Pancreatic and Bladder Carcinoma 151
A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer 151
A SERRS/MRI multimodal contrast agent based on naked Au nanoparticles functionalized with a Gd(iii) loaded PEG polymer for tumor imaging and localized hyperthermia 150
Sensitivity of human leukemia cells in exponential or stationary growth phase to anti-CD5 immunotoxins. Role of intracellular processing events 148
A fluorescence-based assay for the reductase activity of protein disulfide isomerase. 148
A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin 144
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 144
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 144
T cell immune function in newborn infants 143
HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection 143
Disposition of intrathecally administered immunotoxins in rats. A preliminary report 143
Cooperation of Prostate Specific Membrane Antigen with beta 1 integrin promotes the survival of aggressive prostate cancer cells 142
Standardization of in vitro synthesis and detection of HIV-1-specific antibodies 141
Hybridoma cells containing intracellular anti-ricin antibodies show ricin meets secretory antibody before entering the cytosol 141
Characterization of a new anti PSCA monoclonal antibody and scFv fragment for diagnosis and immunotherapy of prostate, pancreatic and bladder carcinoma. 141
Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi 140
Anti-prostate specific membrane antigen targeted gold nanoparticles in tumor therapy and diagnosis 139
Fluorescent Assay to Demonstrate the Interaction of Thioredoxin Reductase and Protein Disulfide Isomerase. 136
EpCAM a possible target for immunotoxin treatments of PSMA positive and negative prostate cancer cells 135
Biodistribution of In-111-labeled D2B IgG, F(ab’)2 and Fab fragments in nude mice bearing human prostate cancer xenografts 135
Heterogeneity and modulation of tumor-associated antigens in human glioblastoma cell lines 134
The prostate specific membrane antigen regulates the expression of IL-6 and CCL-5 in prostate tumour cells by activating the MAPK pathways 133
Mechanisms involved in serum-dependent inactivation of the immunotoxin enhancers monensin and carrier-protein-monensin 132
Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen 132
Problems and potentials in immunotoxin therapy 132
N-terminal deletion affetcs catalytic activity of saporin toxin. 132
The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumor cells by activating the MAPK pathways. 132
Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas 131
Human glioma cell lines: tumour associated antigens distribution and sensitivity to antibody-toxin or ligand-toxin conjugates. A preliminary report 131
Human immune response to ricin A-chain: identification of T-cell and B-cell epitopes. 131
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 131
Production of a biotinylated anti-PSMA single-chain antibody fragment (scFv) for imaging and radioimmunotherapy 129
Investigation of Properties of Anti-Prostate Specific Membrane Antigen-targeted Gold Nanoparticles as Drug Carriers in Tumor Therapy 129
Protein Disulfide Isomerase and Thioredoxin Reductase: a ricin disulfide reducing system in the endoplasmic reticulum. 128
Targeted delivery of photosensitizers: efficacy and selectivity issues revealed by multifunctional ORMOSIL nanovectors in cellular systems 128
The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis 128
Internalization and intracellular fate of anti-CD5 monoclonal antibody and anti-CD5 ricin A-chain immunotoxin in human leukemic T cells 127
Lipid interaction of diphtheria toxin and mutants with altered fragment B. 2. Hydrophobic photolabelling and cell intoxication 127
FLUORESCENT ASSAY TO TEST PROTEIN DISULFIDE ISOMERASE ACTIVITY INDUCED BY THIOREDOXIN REDUCTASE. 126
Plasmonic Nanostructures for SERRS Multiplexed Identification of Tumor-Associated Antigens 126
Characterization of In-111-labeled site-specifically conjugated anti-PSMA antibody-drug conjugates for treatment of PSMA-expressing tumors 126
Sensitivity of human glioma cells to cytotoxic heteroconjugates 125
Prostate-specific membrane antigen associates already in the endoplasmic reticulum with lipid microdomains 125
Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin 124
Thy 1.2+ leukemia cells eradicated from in vitro leukemia-bone marrow cell mixtures by antibody-toxin conjugates 124
Ingegnerizzazione di un vettore per espressione di frammenti anticorpali (scFv) biotinilati in procarioti, purificazione ed analisi funzionale 124
Constitutive activation of p38 and ERK1/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells. 123
Human MBP-specific T cells regulate IL-6 gene expression in astrocytes through cell-cell contacts and soluble factors 122
Selective killing of target cells by antibody-ricin A chain or antibody-gelonin hybrid molecules: comparison of cytotoxic potency and use in immunoselection procedures 121
Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase. 120
The Proinflammatory Cytokine, IL-6, and its Interference with bFGF Signaling and PSMA in Prostate Cancer Cells. 120
Prostate-specific membrane antigen (PSMA) associates early in the endoplasmic reticulum with lipid microdomains 118
Chemical conjugation of ΔF508-CFTR corrector deoxyspergualin to transporter human serum albumin enhances its ability to rescue Cl- channel functions. 118
Tumor Targeting with Guided Silica Nanopartilces for Prostate Cancer Therapy 117
Discriminatory role of detergent-resistant membranes in the dimerization and endocytosis of prostate-specific membrane antigen 117
Top-down synthesis of multifunctional iron oxide nanoparticles for macrophage labelling and manipulation 115
Cloned fragment of diphtheria toxin linked to T cell-specific antibody identifies regions of B chain active in cell entry 114
Peptide analogues of a T-cell epitope of ricin toxin A-chain prevent agonist-mediated human T-cell response in vitro. 114
Parallel optical read-out of micromechanical pillars applied to prostate specific membrane antigen detection 113
Lymphocyte phenotypic subsets in umbilical cord blood compared to peripheral blood from related mothers 113
Potentiation of cytotoxic heteroconjugates by monensin-carrier proteins 112
The Filamin A-mediated cooperation of Prostate Specific Membrane Antigen (PSMA) with beta1 integrin promotes the survival of aggressive prostate cancer cells. 112
Anti-TNF? therapy in rheumatoid arthritis and autoimmunity 112
Identification of Ricin A chain HLA II-restricted epitopes by human T-cell clones. 111
Isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen, conjugates and uses thereof 110
Reductive activation of type 2 ribosome inactivating proteins (RIPs 2) is promoted by transmembrane thioredoxin-related protein (TMX) 110
Generazione di nuovi anticorpi anti prostate stem cell antigen (PSCA) e loro caratterizzazione al fine di un futuro utilizzo nella terapia e nella diagnosi dei carcinomi prostatico, pancreatico e della vescica 109
Cloning and characterisation of canine prostate-specific membrane antigen 109
Magneto-Plasmonic Au-Fe alloy nanoparticles designed for multimodal SERS-MRI-CT imaging 109
Targeting human prostate cancer with (111) In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts. 108
Human large granular lymphocytes contain an esterase activity usually considered as specific for the myeloid series 108
Self-potentiation of ligand-toxin conjugates containing ricin A chain fused with viral structures 108
Effect of therapeutic macromolecules in spheroids 107
Prostate Specific Membrane Antigen (PSMA) associates with Filamin A, beta1 integrin, pp130CAS and pSrc thus regulating the activation of beta1 integrin and the survival of prostate cancer cells. 106
Sensitivity of target cells to immunotoxins: possible role of cell-surface antigens 105
Late generation lentiviral vectors: evaluation of inflammatory potential in human airway epithelial cells. 105
Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin 103
IL-6 gene expression in human astrocytes is enhanced after adhesion to MBP-specific T-cells: role of beta1 integrin and IFN-gamma in the induction of NF-kB and IRF-1 binding activity 102
Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors 101
Pharmacokinetics of intrathecal transferrin-ricin A chain immunotoxins 96
SERS IMAGING OF CANCER CELLS WITH ANTIBODY FUNCTIONALIZED GOLD NANOPARTICLES 95
PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models 95
Totale 13.316
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.197
article - articoli 37.198
book - libri 0
conference - conferenze 12.616
curatela - curatele 0
other - altro 0
patent - brevetti 741
selected - selezionate 0
volume - volumi 1.642
Totale 104.394
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021999 0 0 83 124 165 155 13 110 91 13 191 54
2021/20221.157 111 308 6 99 39 36 29 78 43 29 110 269
2022/20232.478 175 230 210 402 239 577 89 200 262 12 61 21
2023/2024991 55 93 82 134 111 144 30 71 13 80 124 54
2024/20253.027 176 201 65 466 209 126 185 124 469 191 260 555
2025/20261.850 598 528 724 0 0 0 0 0 0 0 0 0
Totale 15.887